Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
5951
CALL
Kyntra Bio
KYNB
$27.6M
| $1.57M | ﹤0.01% |
5,932
+4,488
| +311% | +$1.15M |
|
5952
CALL
Bausch + Lomb
BLCO
$6.07B
| $1.56M | ﹤0.01% |
+102,700
| New | +$1.66M |
|
5953
PUT
Emcor
EME
$38B
| $1.56M | ﹤0.01% |
15,200
+5,100
| +50% | +$545K |
|
5954
Northrim BanCorp
NRIM
$598M
| $1.56M | ﹤0.01% |
155,448
+100,628
| +184% | +$1.03M |
|
5955
Syntax Stratified LargeCap ETF
SSPY
$132M
| $1.56M | ﹤0.01% |
+25,807
| New | +$1.69M |
|
|
TGI
5956
DELISTED
Triumph Group
TGI
| $1.56M | ﹤0.01% |
117,690
-16,288
| -12% | -$309K |
|
5957
PUT
TG Therapeutics
TGTX
$7.54B
| $1.56M | ﹤0.01% |
368,100
-2,900
| -0.8% | -$18.1K |
|
|
FPAC
5958
CALL
DELISTED
Far Peak Acquisition Corporation
FPAC
| $1.56M | ﹤0.01% |
159,200
-60,100
| -27% | -$592K |
|
|
YELL
5959
DELISTED
Yellow Corporation Common Stock
YELL
| $1.56M | ﹤0.01% |
533,355
+124,287
| +30% | +$504K |
|
5960
PUT
Amplitude
AMPL
$1.58B
| $1.56M | ﹤0.01% |
109,300
-28,500
| -21% | -$500K |
|
|
HUT
5961
CALL
Hut 8
HUT
$10.9B
| $1.56M | ﹤0.01% |
234,580
+39,460
| +20% | +$589K |
|
5962
CALL
Brookfield Infrastructure Partners
BIP
$17.9B
| $1.56M | ﹤0.01% |
40,800
-19,950
| -33% | -$820K |
|
5963
CALL
Jack in the Box
JACK
$328M
| $1.56M | ﹤0.01% |
27,800
-3,100
| -10% | -$235K |
|
|
AZPN
5964
PUT
DELISTED
Aspen Technology Inc
AZPN
| $1.56M | ﹤0.01% |
+8,484
| New | +$1.51M |
|
5965
PUT
Insperity
NSP
$1.93B
| $1.56M | ﹤0.01% |
15,600
-4,500
| -22% | -$446K |
|
5966
John Hancock Multifactor Mid Cap ETF
JHMM
$6.21B
| $1.56M | ﹤0.01% |
35,228
+29,845
| +554% | +$1.44M |
|
5967
iShares MSCI Europe Small-Cap ETF
IEUS
$184M
| $1.55M | ﹤0.01% |
32,025
-34,480
| -52% | -$1.91M |
|
5968
iShares MSCI Agriculture Producers ETF
VEGI
$146M
| $1.55M | ﹤0.01% |
+39,649
| New | +$1.78M |
|
|
CHX
5969
DELISTED
ChampionX
CHX
| $1.55M | ﹤0.01% |
78,243
-288,645
| -79% | -$6.52M |
|
5970
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.53B
| $1.55M | ﹤0.01% |
108,557
+12,565
| +13% | +$186K |
|
|
MGIC
5971
PUT
DELISTED
Magic Software Enterprises
MGIC
| $1.55M | ﹤0.01% |
87,400
+29,200
| +50% | +$500K |
|
|
DFND
5972
DELISTED
Siren DIVCON Dividend Defender ETF
DFND
| $1.55M | ﹤0.01% |
+46,324
| New | +$1.6M |
|
5973
PUT
Pacira BioSciences
PCRX
$926M
| $1.55M | ﹤0.01% |
26,600
-26,300
| -50% | -$1.72M |
|
5974
CALL
Prelude Therapeutics
PRLD
$449M
| $1.55M | ﹤0.01% |
297,200
+125,800
| +73% | +$640K |
|
5975
CALL
ENI
E
$80.9B
| $1.55M | ﹤0.01% |
65,100
+45,000
| +224% | +$1.28M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.